tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Teva sees mid-single revenue growth (CAGR ’23-’27)

Says “on track” to achieve 2027 financial targets. Targeting 2027 adjusted operating income margin 30%; net debt/adjusted EBITDA 2.0x; cash to earnings 80%. Comments taken from investor presentation slides.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1